SE0303419D0 - New use 11 - Google Patents

New use 11

Info

Publication number
SE0303419D0
SE0303419D0 SE0303419A SE0303419A SE0303419D0 SE 0303419 D0 SE0303419 D0 SE 0303419D0 SE 0303419 A SE0303419 A SE 0303419A SE 0303419 A SE0303419 A SE 0303419A SE 0303419 D0 SE0303419 D0 SE 0303419D0
Authority
SE
Sweden
Prior art keywords
new use
functional
mglur5
antagonists
treatment
Prior art date
Application number
SE0303419A
Other languages
English (en)
Inventor
Haakan Larsson
Anders Lehmann
Erik Lindstroem
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303419A priority Critical patent/SE0303419D0/sv
Publication of SE0303419D0 publication Critical patent/SE0303419D0/sv
Priority to US10/582,182 priority patent/US20070123551A1/en
Priority to CNA2004800364623A priority patent/CN1889953A/zh
Priority to PCT/SE2004/001819 priority patent/WO2005058321A1/en
Priority to EP04801726A priority patent/EP1696916A1/en
Priority to JP2006545280A priority patent/JP2007514741A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
SE0303419A 2003-12-17 2003-12-17 New use 11 SE0303419D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0303419A SE0303419D0 (sv) 2003-12-17 2003-12-17 New use 11
US10/582,182 US20070123551A1 (en) 2003-12-17 2004-12-07 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders
CNA2004800364623A CN1889953A (zh) 2003-12-17 2004-12-07 代谢型谷氨酸受体5(mGLuR5)拮抗剂用于治疗胃肠机能紊乱的用途
PCT/SE2004/001819 WO2005058321A1 (en) 2003-12-17 2004-12-07 USE OF METABOTROPIC GLUTAMATE RECEPTOR 5 (mGLuR5) ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS.
EP04801726A EP1696916A1 (en) 2003-12-17 2004-12-07 Use of metabotropic glutamate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders
JP2006545280A JP2007514741A (ja) 2003-12-17 2004-12-07 消化管障害の治療のための代謝調節型グルタミン酸受容体５（ｍＧＬｕＲ５）拮抗剤の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303419A SE0303419D0 (sv) 2003-12-17 2003-12-17 New use 11

Publications (1)

Publication Number Publication Date
SE0303419D0 true SE0303419D0 (sv) 2003-12-17

Family

ID=30439732

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303419A SE0303419D0 (sv) 2003-12-17 2003-12-17 New use 11

Country Status (6)

Country Link
US (1) US20070123551A1 (sv)
EP (1) EP1696916A1 (sv)
JP (1) JP2007514741A (sv)
CN (1) CN1889953A (sv)
SE (1) SE0303419D0 (sv)
WO (1) WO2005058321A1 (sv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020001A1 (en) * 1998-10-02 2000-04-13 Novartis Ag Mglur5 antagonists for the treatment of pain and anxiety
CA2442478C (en) * 2001-04-02 2010-02-02 Mark F. Bear Use of group i mglur antagonists in the treatment of fragile x syndrome, autism, mental retardation
US7071335B2 (en) * 2002-02-01 2006-07-04 Euro-Celtique S.A. 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain

Also Published As

Publication number Publication date
US20070123551A1 (en) 2007-05-31
JP2007514741A (ja) 2007-06-07
CN1889953A (zh) 2007-01-03
EP1696916A1 (en) 2006-09-06
WO2005058321A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
NO20034289L (no) N-(2-aryletyl)benzylaminer som antagonister av 5-HT6- reseptoren
SE0202241D0 (sv) Novel Compounds
DE602006007556D1 (de) Heteroarylsulfonylstilbene als 5-ht2a-antagonisten
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
DK1723144T3 (da) Yderligere heteropolycykliske forbindelser og anvendelse deraf som metabotropiske glutamareceptor-antagonister
WO2003028641A3 (en) Mch receptor antagonists
SE0303180D0 (sv) Novel compounds
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
SE0302232D0 (sv) Novel Compounds
NO20072965L (no) Potentiatorer av glutamatreceptorer
MY153719A (en) Prokineticin 1 receptor antagonists
ATE537170T1 (de) Cgrp-rezeptorantagonisten
TW200716566A (en) Prokineticin 2 receptor antagonists
ATE503755T1 (de) Cgrp-rezeptorantagonisten
ATE399770T1 (de) Tachykininrezeptorantagonisten
ATE507880T1 (de) Cgrp-rezeptorantagonisten
EA200600860A1 (ru) Производные n-тиазол-2-илбензамида
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
SE0303419D0 (sv) New use 11
NO20044473L (no) Ikke-steroidal progesteron reseptor modulatorer
EA200600416A1 (ru) Производные циклопропила в качестве антагонистов рецептора nk3
NO20081529L (no) Naftyridinderivater
SE0303488D0 (sv) New use 1X